APTO
Aptose Biosciences, Inc.
APTO
APTO
Delisted
APTO was delisted on the 1st of April, 2025.
44 hedge funds and large institutions have $13.5M invested in Aptose Biosciences, Inc. in 2023 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 12 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
44
Holding in Top 10
–
Calls
$8K
Puts
–
Top Buyers
| 1 | +$239K | |
| 2 | +$7.63K | |
| 3 | +$4.9K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$2.64K |
| 5 |
JMF
Johnson Midwest Financial
Glidden,
Iowa
|
+$1.46K |
Top Sellers
| 1 | -$687K | |
| 2 | -$212K | |
| 3 | -$198K | |
| 4 |
Millennium Management
New York
|
-$107K |
| 5 |
Renaissance Technologies
New York
|
-$106K |